In 1996, Dr Walter Willett of Harvard University authored a report in the Journal of The National Cancer Institute stating that, after reviewing the world-wide evidence, approximately 50% of breast cancer cases could be avoided if women in North America engaged in more prudent nutrition and lifestyle practices.
In 1996, Dr Walter Willett of Harvard University authored a report in the Journal of The National Cancer Institute stating that, after reviewing the world-wide evidence, approximately 50% of breast cancer cases could be avoided if women in North America engaged in more prudent nutrition and lifestyle practices. It has been shown consistently that having a full-term pregnancy and breast feeding before age 30 reduces a woman’s lifetime risk of breast cancer by 25-30%, and that another 20-25% of breast cancer cases are linked to a strong family history (genetic risk factors). However, the remaining 50% of breast cancer cases are strongly linked to faulty nutrition patterns, excess body fat and insufficient exercise, according to numerous investigative studies on this subject. (1,2)
During the past ten to twelve years compelling evidence has emerged from research investigations, which identify the most important dietary and lifestyle strategies women should consider to reduce their risk of breast cancer. According to the available research, the following represents the 10 most important steps women should consider in this regard:
Don’t eat high fat animal foods (except fish)
Eating less red meat, pork, milk and yogurt products higher than 1% milk fat, cheeses above 3% milk fat, whole milk, butter, ice cream, cream, whipped cream and the like, is the first vital step in reducing breast cancer risk. These foods are not only high in saturated fat, which can over stimulate production of estrogen, but they also contain a polyunsaturated fat known as AA (arachidonic acid). Breast tissue converts AA into local mini hormones (eicosanoids) that increase cell replication rate of breast cells. When breast cells divide too quickly they are inclined to make genetic errors that lead to breast cancer development. This is how hormone replacement therapy increases risk of breast cancer (by speeding up the cell replication rate). Follow-up studies on humans and numerous animal studies show that higher breast tissue concentrations of AA increase the risk of future onset of breast cancer. Overall, the goal is to slow down the rate of breast cell replication. When you do that, cancer is less likely to develop. Eating less high animal fat foods is an important first step, as is remaining at your ideal weight and exercising, as we shall touch on next. Thus, if becoming a vegetarian is out of the question (vegetarians have low rates of breast cancer) it is best to derive your protein from chicken and turkey breast (skinless), Cornish hen, fish, soy products, peas and beans, egg whites, non fat yogurt and milk (or 1%) and cheese that is less than 4% milk fat. (3,4,5,6)
It is a medical fact that women who are over weight after menopause have a three times greater incidence of breast cancer than women who are at their ideal weight. Studies, such as the New York University Women’s Health Study, indicate that as women become fatter they increase production of estrone hormone in their fat tissues (estrone is potent form of estrogen). The higher circulating levels of estrone in the body of an over weight woman, in turn, over-stimulate breast cells, leading to more rapid cell replication. As we said, faster cell replication rates increase risk of breast cancer development. Not only that, but should breast cancer develop, breast cancer cells convert estrone hormone into an even more potent estrogen, known as estradiol, which bolsters the ability of breast cancer cells to form masses and more readily metastasize to other areas of the body. The message is clear and simple – attain and maintain your ideal body weight. Very conveniently, giving up foods high in animal fat will help you get leaner, as will performing 30-minutes of endurance exercise, 5 times per week, which we will examine next. (7,8,9)
Perform A Minimum Of 30 Minutes Of Endurance Exercise, Five Times Per Week
Numerous studies indicate that women who are more active have a lower incidence of breast cancer. Endurance exercise is extremely useful because it burns fat, making fat cells smaller. When fat cells are smaller they make less estrone hormone, and thus, are less likely to over-stimulate breast cells. This effect slows down the rate of replication of breast cells, which translates into a lower risk for breast cancer. As well, jogging, power walking, cycling, and all other aerobic exercises speed up circulation of blood through the liver, enabling detoxification enzymes (which reside in the liver) to neutralize and remove excess estrogen from the circulation. In turn, this helps to keep female hormones in balance, which ultimately helps regulate the breast cell replication rate. (10,11)
Take A High Potency Multiple Vitamin Containing Vitamin E Succinate and Vitamin D
Investigative studies show that vitamin E succinate has important anti-cancer properties in regards to breast cancer. Vitamin E succinate has been shown to encourage certain types of human breast cancer cells to commit suicide by stimulating action of the cell’s death receptors (fas-receptors). Vitamin E succinate also disrupts other signals within breast cancer cells, which inhibit cell replication and inhibit breast cancer cells from forming blood vessels to feed themselves. All of these effects are associated with decreased risk of breast cancer development. Overall, in all experimental and animal studies performed to date, only vitamin E in the form of vitamin E “Succinate” has demonstrated these powerful inhibitory effects against breast cancer (and other cancers).
As for vitamin D, human observation studies indicate that women with vitamin D blood levels above 85 nmol/L have a lower risk of developing breast cancer. We know that breast cells extract vitamin D from the bloodstream, which in turn, slows down the rate of cell replication of breast cells. Vitamin D also encourages breast cells to fully mature as they divide from one generation to the next. Fully mature cells are less prone to becoming cancer cells than are less mature-looking cells. As such, vitamin D is now regarded as a very important anti-cancer vitamin, in addition to its role in preventing osteoporosis. Most women do not achieve the vitamin D intake levels required each day to protect themselves from breast cancer and osteoporosis. Therefore, it is very prudent to take a high potency multiple vitamin and mineral supplement each day that provides 400 IU of vitamin D along with 400 IU of Vitamin E Succinate. (12-20)
Drink Less Alcohol And Get A B-50 Complex, As Part Of Your High Potency Multiple Vitamin and Mineral Supplement
The Nurses’ Health Study, along with other compelling evidence, indicates that women who consume more than one alcoholic drink each day, on average, double their risk of breast cancer (and colon cancer). Alcohol is known to generate free radicals that can lead to genetic mutations, which trigger cancer development. The body appears to have a capacity to handle only one alcoholic drink in any 24-hour period before risk begins for cancer and other problems. As such, after cigarette smoking, the National Cancer Institute states that alcohol consumption is the second most important environmental cause of cancer in our society. Alcohol also depletes the body of folic acid, which is a B-vitamin required for our DNA to replace itself when cells are undergoing replication. In a state of sub-optimal folic acid status, our DNA tends to be fragile and cancer cells form more easily when cells replace themselves from one generation to the next. Even the Nurses’ Health Study showed that higher intakes of folic acid could reduce, to some degree, the cancer-causing effects of alcohol, in women who took a B vitamin supplement each day. As many of the B-vitamins work together in the body, it is wise to take a B-50 complex, as part of your daily multiple vitamin and mineral supplement. This advice, along with consuming no more that one alcoholic drink within any 24-hour period are also important preventive measures against breast cancer. (21-24)
Take A Supplement Containing Fish Oil, Flaxseed Oil and Borage Seed Oil and Eat Fish Twice Per Week
Fish and fish oil supplements contain an omega-3 fat that breast cells convert into a mini-hormone that slows down the rate of cell replication. Women with higher levels of this omega-3 fat in their breast cells (as well as the omega-3 fat that is richly supplied by flaxseed oil – alpha-linolenic acid) have been shown to have a significantly lower risk for future development of breast cancer, compared to women with lower breast levels of these omega-3 fats. Studies also show that the higher your ingestion of omega-3 fats, the higher will be your breast tissue levels of these fats, as well as the health-promoting mini hormones your breast cells make from these fats. Borage seed oil contains a unique omega-6 fat that helps the body block the formation of mini-hormones made from AA (as discussed above). Thus, higher breast cell levels of fish oil, flaxseed oil and borage oil, help to counter the adverse effects of the AA (arachidonic acid) derived from high fat animal foods. The ultimate strategy in this regard is eat less high-fat animal foods, while consuming two to three servings of fish each week, and to take a supplement each day that contains 400 mg each of fish oil, flaxseed oil and borage seed oil (take 2-3 capsules per day for optimal effects). (5,25,26,27)
Consume Cruciferous Vegetables and Indole-3-Carbinols Daily
Human studies demonstrate that women, who consume cruciferous vegetables (broccoli, Brussels sprouts, cabbage, cauliflower, bok choy) on a regular basis, have a lower incidence of breast cancer. Cruciferous vegetables contain a unique molecule called the indole-3-carbinol, which enhances the ability of the body to detoxify cancer-causing agents. Indole-3-carbinol also stimulates enzymes that convert estrogen into a safer form of estrogen (more 2-hydroxy estrone and less 16-hydroxy estrone) that is associated with a lower risk of breast cancer. As such, it is prudent to consume at least one serving per day of a cruciferous vegetable. Some women take it one step further and consume a supplement each day that contains Indole-3-Carbinol, along with Milk Thistle (milk thistle also enhances detoxification enzyme activity and supports liver function) and immune boosting agents (reishi mushroom extract and astragalus). (28-32)
Consider Supplementation With Curcumin and Other Natural Anti-Inflammatory Agents
In recent years we have recognized that as much as 40% of breast cancer occurs in women who, for genetic reasons) express an abnormally high number of receptors on the surface of their breast cells known as Epidermal Growth Factor Receptors. There are four types of receptors in the family of Epidermal Growth Factor Receptors and women who are genetically prone to breast cancer tend to over express the Type-2 Epidermal Growth Factor Receptor, usually referred to as ErbB2. This receptor (ErbB2) sends continuous messages to the interior of the breast cell, instructing the cell to replicate on an on-going basis, speeding up cell replication and increasing risk of cancer. As such, medical science has been looking for a drug or chemical agent that could inhibit the firing of the ErbB2 receptor, and thus slow down breast cell replication rate. In recent years medical science has produced a drug (a monoclonal antibody) called Herpecetin, that does exactly that, which is now used in some cases of breast cancer treatment. However, the drug has unpleasant side effects and can not be used on a preventive basis. Interestingly, the natural agent called curcumin (derived from the spice turmeric) has been shown to silence the ErbB2 receptor without causing side effects. A recent study with human colon cancer patients showed that curcumin supplementation reduced the recurrence of colon cancer in this high-risk population. In this type of colon cancer Epidermal Growth Factor Receptors are also over-expressed and contribute to constant signaling that leads to rapid cell replication and cancer development. Experimental studies suggest that curcumin may help to silence ErbB2 breast receptors as well. In addition, supplementation with the natural anti-inflammatories, white willow bark extract, boswellia and ginger help the body block the conversion of AA (arachidonic acid) into mini-hormones that cause rapid cell replication. This is how aspirin is related to lower risk of breast, colon and prostate cancers. However, aspirin causes intestinal tract bleeding and ulcers and thus, can not be recommended as a cancer preventive strategy for these reasons. Many holistic doctors recommend, as an alternative, supplementation with a combination product containing curcumin, white willow extract, boswellia and ginger. These four natural agents work synergistically to help regulate Epidermal Growth Factor Receptors and block the production of mini-hormones involved in rapid cell division at the tissue level. (33-49)
Take Two Heaping Tablespoons of Ground Flaxseed Each Day
Ground flaxseeds contain 800 times more of the raw material from which the body makes two important phytoestrogens (Enterolactone and Enterodiol) than any other food source. Enterolactone (ENL) and enterodiol (EDL) have been shown to slow down the rate of breast cell replication by competing with the body’s potent estrogens for entry into breast cells, by inhibiting enzymes that produce highly potent estrogens and by inhibiting enzymes directly involved in cell replication. Human studies demonstrate that 50 gm of ground flaxseed per day can reverse fibrocystic breast disease and tone down the firing of the ErbB2 receptor that is associated with breast cancer development and progression. All indicators suggest that two heaping tablespoons of ground flaxseed per day (e.g. sprinkled onto cereal, mixed into yogurt, or mixed into juice or a protein shake) is an exceptional way to help control regulatory mechanisms at the cell level that are associated with reducing breast cancer risk.(50-59)
Eat At Least One Serving Of A Soy Food Each Day
Although there is controversy about soy and breast cancer, the evidence is quite convincing that consuming soy foods provides significant protection against reproductive organ cancers in women and men. To start with, breast cancer rates are 75% lower in countries where soy foods are a main staple of the daily diet. Experimental evidence indicates that soy isoflavones (phytoestrogens) exhibit a number of anti-cancer properties, some of which include, toning down the effects of more potent estrogens, inhibiting enzymes that are directly related to rapid cell division, and enhancing the conversion of potent estrogens to less potent estrogens, all of which slow down the rate of breast cell replication – a major factor in reducing breast cancer development. Most recently, a study involving breast cancer patients showed that providing them with 200 mg per day of soy isoflavones (as a supplement) helped to shrink the tumors (increased the apoptosis to mitosis ratio) while the patients were awaiting surgery. In my view, women should consume at least one generous serving per day of a soy food (soy milk, tofu, soy nuts, etc.) as a means to derive the health-promoting benefits of soy isoflavones and other constituents found exclusively in soy foods. (60-67)
My suggestion is that you speak to your health practitioner about that appropriateness of these strategies in your individual case and seek their guidance as to how to access supplements that meet the requirements outlined in this review.
1. Willet, W. Estimates of cancer deaths avoidable by dietary change. J Natl Cancer Instit., 1996; 86, 14: 948
2. Cancer and Nutrition. Simone, B. Avery Publishing Group Inc., 1992:219-23
3. Rose DP. Dietary fatty acids and cancer. Am J Clin utr. 1997;66(suppl):998S–1003S.
4. Carroll, K K. Experimental evidence of dietary factors and hormone-dependent cancers. Cancer Res 1975;35:3374-83
5. Pala, Valeria, et al. Erythrocyte membrane fatty acids and subsequent breast cancer: a prospective Italian study. Journal of the National Cancer Institute, Vol. 93, July 18, 2001, pp. 1088-95
6. Dwyer, J T Health aspects of vegetarian diets, 1988. Am J Clin Nut;48:712-38
7. Toniolo, et al. A Prospective Study of Endogenous Estrogens and Breast Cancer in Postmenopausal Women. JNCI 1995; 87(3): 190-199
8. Lew, E.A., et al. The American Cancer Society Study; Variations in mortality by weight among 750,000 men and women. J Chronic Dis 1979; 32: 563-76
9. Tannenbaum, A. The relationship of body weight to cancer incidence Arch Pathol 1940; 30: 509
10. Sprague BL, Trentham-Dietz A, Newcomb PA, Titus-Ernstoff L, Hamptom JM, Egan K. Lifetime Recreational and Occupational Physical Activity and Risk of In situ and Invasive Breast Cancer. Cancer Epidemiology Biomarkers & Prevention 16, 236-243, 2007.
11. Steege, J.F., et al. The effects of aerobic exercise on premenstrual symptoms in middle-aged women: a preliminary study. J Psychosom Res., 1993; 37, 2: 127-133
12. Malafa MP, Neitzel LT. Vitamin E succinate promotes breast cancer dormancy. J Surg Res; 93(1): 163-70. 2000
13. Fang X, Birringer M, Dong L, Veprek P, Low P et al. A peptide conjugate of vitamin E succinate targets breast cancer cells with high ErbB2 expression. Cancer Research; 67: 33373344.2007
14. Yu W, Israel K, Liao Q, Aldaz CM, Sanders BG and Kline K. Vitamin E succinate (VES) induces Fas sensitivity in human breast cancer cells. Cancer Research; 59:953-961. 1999
15. Garland CF, et al. Can colon cancer incidence and death rates be reduced with calcium and vitamin D? Am J Clin Nutr 1991;54(Suppl 1):193S-201S.
16. Garland CF, Garland FC, Gorham ED. Calcuim and vitamin D. Their potential roles in colon and breast cancer prevention. Ann NY Acad Sci 1999;889:107-19.
17. Garland FC, et al. Geographic variation in breast cancer mortality in the United States: a hypothesis involving exposure to solar radiation. Prev Med 1970;19:614-22.
18. Schmidt J, Wittenhagen P, Harder M. Molecular effects of vitamin D on cell cycle and oncogenesis. Ugeskrift for laeger 1998 Jul 20;160(30):4411-4.
19. Lappe JM et al. Vitamin D and calcium supplementation reduces cancer risk: results of a randomized trial. Am J Clin Nutr. 2007;85:1586-91
20. Longnecker M. Alcoholic beverage consumption in relation to risk of breast cancer: meta-analysis and review. Cancer Causes Control 1994;5(1):73-82.
21. Smith-Warner SA, Spiegelman D, Yaun SS, van den Brandt PA, Folsom AR, Goldbohm RA, et al. Alcohol and breast cancer in women: a pooled analysis of cohort studies. JAMA 1998;279(7):535-40
22. Giovannucci, et al. Folate, methionine, and alcohol intake and risk of colorectal adenoma. J. Natl Cancer Inst. 1993;85(11):875-83
23. Goelez SE, Vogelstein B, Hamilton SR, et al. Hypomethylation of DNA from benign and malignant human colon neoplasms. Science 1985;228:187-190
24. Yee LD, Young DC, Rosol TJ, VanBuskirk AM and Clinton SK. Dietary (n-3) polyunsaturated fatty acids inhibit HER-2/neu-induced breast cancer in mice independently of the PPPAR gamma ligand rosiglitazone. The American Society for Nutritional Sciences J. Nutr. 2005,;135:983-988.
25. Bougnoux P, Koscielny S, Chajes V, et al. Alpha-linolenic acid content of adipose breast tissue: a host determinant of the risk of early metastasis in breast cancer. Br J Cancer. 1994;70:330–334.
26. Fan, Yang-Yi and Chapkin RS. Importance of dietary gamma -linolenic acid in human health and nutrition. Journal of Nutrition 128 (9): 1411-1414. 1998)
27. Hecht, S.S. Chemoprevention of cancer by isothiocyanates, modifiers of carcinogen metabolism. J Nutr 1999; 129: 7688-74S
28. Verhoeven, D.T., Goldbohm, R.A., van Poppel, G., et al. A review of mechanisms underlying anticarcinogenicity by brassica vegetables. Chem Biol Interact 1997; 103: 79-129 [review]
29. Beecher, C.W. Cancer preventive properties of varieties of Brassica oleracea: a review. Am J Clin Nutr. 1994 May; 59 (5 suppl): 1166S-1170S
30. Osborne, M.P., et al. (1993) Increase in the extent of estradiol 16 alpha-hydroxylation in human breast tissue: A potential biomarker of breast cancer risk. JNCI 85: 1917-20
31. Michnovicz, J.J. Increased estrogen 2-hydroxylation in obese women using oral indole-3-carbinol. Int J Obes Relat Metab Disord 1998; 22: 227-9
32. Reddy S, Rishi A.K., Xu H et al. Mechanisms of curcumin-and EGF-receptor related protein (ERRP) – dependent growth inhibition on colon cancer cells. Am J Clin Nutr, 55; 2: 185-194. 2006
33. Ciardiello, F, Caputo R, Bianco, R. Antitumor Effect and Potentiation of Cytotoxic Drugs Activity in Human Cancer Cells by ZD-1839 (Iressa), an Epidermal Growth Factor Receptor-selective Tyrosine Kinase Inhibitor. Clinical Cancer Research; 6: 2053-2063, May 2000
34. Ciardiello F and Tortora G. Interactions between the epidermal growth factor receptor and type I protein kinase A: biological significance and therapeutic implications. Clinical Cancer Research, 4,; 4: 821-828: 1998
35. Al-Achi. Anti-inflammatory Herbs. U.S. Pharmacist. 29:03 (Posted 03/15/2004)
36. Satoskar R R et al. Evaluation of anti-inflammatory property of curcumin in patients with post-operative inflammation. Int J Clin Pharmacal Ther Toxical 1986; 24:651-54.
37. Murray M T. The Healing Power of Herbs. Prima Publishing, Rocklin CA; 1995: 327-35.
38. Arora R B et al. Anti-inflammatory studies on curcuma longa (turmeric). Ind J Med, Res 1971; 50: 1289-95.
39. Heck A. et al. Potential interactions between alternative therapies and warfarin. Am J Health – Syst Phar, 2000; 57, 13: 1221-1227.
40. Schweizer S et al. Workup-dependent formation of 5-lipoxygenase inhibitory boswellic acids analogues. J Nat Prod 2000, Aug; 63 (8): 1058-1061.
41. Etzel R. Special extract of boswellia serrata (H15) in the treatment of rheumatoid arthritis. Phytomed 1996; 3: 91-94.
42. Bradley P R et al. British Herbal Compendium, Vol 1, Bournemouth, Dorset, UK: British Herbal Med Assoc., 1992, 224-26.
43. Mills S Y et al. Effects of a proprietary herbal medicine on the relief of chronic arthritic pain: A double-blind study. Br J Rheum 1996; 35: 874-78.
44. Chrubasik S et al. Treatment of low back pain exacerbations with willow bark extract: a randomized double – blind study. Am J Med 2000 July; 109 (1):9-14.
45. Srivastava K C et al. Ginger in rheumatism and musculoskeletal disorders. Medical Hypotheses 1992; 39:342-8.
46. Bliddal H et al. A randomized placebo – controlled, cross-over study of ginger extracts and ibuprofen in osteoarthritis, osteoarthritis cartilage 2000, Jan; 8 (1): 9-12.
47. García-Mediavilla V, Crespo I, Collado PS, Esteller A, Sánchez-Campos S et al. The anti-inflammatory flavones quercetin and kaempferol cause inhibition of inducible nitric oxide synthase, cyclooxygenase-2 and reactive C-protein, and down-regulation of the nuclear factor kappaB pathway in Chang Liver cells European Journal of Pharmacology,557;2-3:221-229.
48. Steele VE, Holmes CA, Hawk ET, Kopelovich L, Lubet JA et al. Lipoxygenase inhibitors as potential cancer chemopreventives. Cancer Epid Biomarkers and Prevention, 8;467-4893.1999.
49. Jacobs E.J. et al. A large cohort study of long-term daily use of adult-strength aspirin and cancer incidence Journal of the National Cancer Institute; 99; 8: 608-615. 2007
50. Nesbitt PD et al. Human metabolism of mammalian lignan precursors in raw and processed flaxseed. Am J Clin Nutr 1995;69(3):549-55
51. Huthcins AM et al. Flaxseed influences urinary lignan excretion in a dose-dependent manner in postmenopausal women. Cancer Epidemiol Biomarkers Prev 2000;9(10):1113-8
52. Tham DM et al. Clinical Review 97 : Potential health benefits of dietary phytoestrogens : a review of the clinical, epidemiological, and mechanistic evidence. J Clin Endocrinol Metab 1998;83(7):2223-35
53. Zeigler J. Just the Flax, Ma’am: Researchers Testing Linseed. J Natl Cancer Instit 1994;86(23):1746-8
54. Brzzinski A, Debi A. Phytoestrogens: the natural selective estrogen receptor modulators? Eur J Obstet Gynecol Reprod Biol 1999;85(1):47-51
55. Tou JC, Thompson LU. Exposure to flaxseed or its lignan component during different developmental stages influences rat mammary gland structures. Carcinogenesis 1999;20(9):1831-5
56. Haggans CJ et al. Effect of flaxseed consumption on urinary estrogen metabolites in postmenopausal women. Nutr Cancer 1999;33(2):188-95
57. Haggans CJ et al. The effect of flaxseed and wheat bran consumption on urinary estrogen metabolism in premenopausal women. Cancer Epidemiol Biomarkers Prev 2000;9(7):719-25
58. Thompson LU et al. Antitumorigenic effect of mammalian lignan precursor from flaxseed. Nutr Cancer 1996;26:159-65
59. Gross PE et al. Effect of dietary flaxseed in women with cyclical mastalgia. Program and abstract of the 23rd Annual San Antonio Breast Cancer Symposium. Dec 6-9 2000; San Antonio Texas. Abstract 153. Breast Cancer Res Treat. 2000;64:49
60. Muir C, Waterhouse J, Mack T, Powell J, Whelan S. Cancer incidence in five continents. Vol. 5 Lyon, France: International Agency for Research on Cancer, 1987. (IARC Scientific publication no. 88).
61. Coward L, Barnes NC, Setchell KDR, Barnes S. The isoflavones genistein and daidzein in soy bean foods from American and Asian diets. J Agric Food Chem 1993; 41: 1961-7.
62. Barnes S, Grubbs C, Setchell KDR, Carlson J. Soybeans inhibit mammary tumor growth in models of breast cancer. In: Pariza MW, ed. Mutagens and carcinogens in the diet. New York: Wiley-Liss, 1990: 239-53.
63. Cassidy A et al. Biological effects of a diet of soy protein rich in isoflavones on the menstrual cycle of premenopausal women. Am J Clin Nutr 1994; 60:333-40.
64. Molteni A, Brizio-Molteni L, and Persky V. In vitro hormonal effects of soybean isoflavones. 1995. J Nutr, 125: suppl:751S-756S
65. Chen X and Anderson JJB. Isoflavones inhibit proliferation of ovarian cancer cells in vitro via an estrogen receptor-dependent pathway. 2001. Nutr and Cancer, 41;1&2: 156-17
66. Constantinou AI, Lantvit D, Hawthorne M et al. Chemopreventive effects of soy protein and purified isoflavones on DMBA-induced mammary tumors in female Sprague-Dawley rats. 2001. Nutr and Cancer, 41;1&2: 75-81
67. Sartippour MR, Rao JY, Apple S et al. A pilot clinical study of short-term isoflavone supplements in breast cancer patients. 2004. Nutr and Cancer, 49;1: 59-65